TUESDAY Feb. 11, 2014, 2014 -- The U.S. Food and Drug Administration announced Tuesday that it will investigate possible links between the diabetes drug saxagliptin and a heightened risk for heart failure among users. In a statement, the ...
Tags: FDA, Diabetes Drug, Heart Failure, NEJM
A certain type of diabetes drug may lower cancer risk in women with type 2 diabetes by up to one-third, while another type may increase the risk, according to a new study. Cleveland Clinic researchers analyzed data from more than 25,600 ...
Tags: diabetes drug, lower cancer risk, women with type 2 diabetes
Widely used diabetes drugs have different effects on men's and women's hearts, a new study suggests. Researchers examined how three commonly prescribed treatments for type 2 diabetes affected 78 patients who were divided into three ...
Tags: diabetes drugs, different effects between men and women
People with type 2 diabetes might be at somewhat higher risk of developing liver cancer, according to a large, long-term study. The research suggests that those with type 2 diabetes have about two to three times greater risk of developing ...
Tags: type 2 diabetes, liver cancer, hepatocellular carcinoma
About 30 percent of heart attacks, strokes and deaths from heart disease can be prevented in people at high risk if they switch to a Mediterranean diet rich in olive oil, nuts, beans, fish, fruits ...
Tags: mediterranean, diet, health, heart disease
If you take Byetta or Januvia to control your blood sugar levels, you might have a small, but increased risk for a condition marked by stomach pain and nausea. Not only are the drugs more expensive and no more effective than our Best Buy ...
Tags: Byetta, Januvia, blood sugar levels, diabetes
The USFDA has issued final approval to manufacture and market Aurobindo Pharma's diabetes drugs, Pioglitazone tablets and Pioglitazone Hydrochloride + Metformin Hydrochloride tablets. Pioglitazone Tablets USP 15mg, 30mg & 45mg and ...
Tags: USFDA, Aurobindo Pharma, diabetes drugs
The European Commission has issued clearance to market Novo Nordisk's diabetes therapies, Tresiba and Ryzodeg, across 27 European Union (EU) states. Novo Nordisk anticipates launching Tresiba, brand name of insulin degludec, in the UK and ...
Tags: Ryzodeg diabetes drugs, injection doses, diabetes therapies
A new study by UCLA has discovered that study partners play a key role in clinical trials for Alzheimer's disease. These people provide patients with support while updating researchers about progress, with the new research finding how a ...
Tags: Instruments, Meters, disease trials, UCLA